The pursuit of new and better therapies, especially personalised therapies, remains the innovation motor of biomedical research. An especially high-profile area is imaging of integrin receptors. The cell surface receptors Integrins are family of receptors involved in adhesion, migration and signalling. These are involved in immune responses, wound healing and, especially, cancer recurrence. Imagery of integrin receptors opened the doors to more precise drug design and more precise disease modeling. The focus of this post is on why integrin receptors are important, imaging technology and its impact on the development of new drugs.

Understanding Integrin Receptors

Integrins are alpha- and beta-heterodimer transmembrane receptors. These receptors help a cell to attach itself to its extracellular matrix (ECM) or other cells. Integrins' interactions with ligands in turn cause intracellular signalling cascades that control all sorts of cell-based functions, from growth and differentiation to survival.

Figure 1. Schematic representation of tumors with high RGD-binding integrin expression, which drives tumor progression, metastasis, and angiogenesis. (Bogdanović B, et al.; 2024)

Integrins are grouped according to ligand affinity and beta subunit type. The v3 and v5 integrins, for example, bind to vitronectin; the 51 integrin to fibronectin. Because integrin receptors are so diverse and found widely in different tissues, they play important roles in physiology and pathology.

Integrins and Disease: What They Do and How They Act?

As such, they are involved in many diseases because they are central to cell adhesion and movement. Integrins in cancer aid the invasion and spread of tumour cells by mediating their interactions with the ECM and the ejection of cancer cells from the original tumour. Overexpression of some integrins (like v3) has been linked to a poor prognosis in various cancers.

Integrins are involved in atherosclerotic plaque formation and vascular injury response in cardiovascular diseases. Integrin-induced adhesion and signalling bring in the inflammatory cells to the injury location, worsening the disease process.

Integrins are also central in immune system function. It relies on integrins of leukocytes (like LFA-1 (L2)) to traffic and activate immune cells. autoimmune diseases or chronic inflammation can be caused by malfunctioning or over-activation of these integrins.

Imaging Integrin Receptors: Methods and Developments

Visualisation of integrin receptors in the living world gives insight into how they are distributed, expressed and functional in disease. The imaging modalities have been honed to do this, and each has its own strengths and uses.

1. Positron Emission Tomography (PET)

PET imaging is an extremely sensitive tool that could quantify the level of integrin in real time. Tracers include radiolabelled ligands or antibodies that attach specifically to integrins. [18F]Galacto-RGD, for instance, is a PET tracer targeting v3 integrin, which is overexpressed in tumours and angiogenic blood vessels. With this tracer PET can be used for non-invasive detection of tumor integrin expression and anti-angiogenic therapy.

2. Magnetic Resonance Imaging (MRI)

MRI shows ultra-high resolution anatomical photographs and, with contrast agents applied to the targeted regions, can also see integrin expression. SPIONs in combination with RGD peptides (again targeting v3 integrin) brighten the MRI images showing regions of enriched integrin expression. It's especially handy when looking to visualize tumor angiogenesis and spread.

3. Optical Imaging

Fluorescence and bioluminescence imaging can be scanned with high sensitivity and specificity for imaging integrin receptors. Image integrin expression in live animals with fluorescently labeled peptides or antibodies. Near-infrared fluorescence (NIRF) imaging with greater tissue penetration and less background signal is very useful for in vivo studies.

4. Single-Photon Emission Computed Tomography (SPECT)

SPECT imaging – like PET – uses radiolabeled ligands to show the expression of integrins. Using isotopes such as 99mTc or 111In, linked to integrin-binding peptides, one can identify and measure integrin in tumours and other tissues. SPECT imaging can be useful in follow-up and evaluation of integrin-directed therapy pharmacodynamics.

Integrin Imaging in Drug Development

Integrin receptor imaging has a number of advantages from discovery to clinical trials when used in drug development.

1. Target Validation

Embedding integrin receptors is another way for scientists to confirm their function in disease models. When scientists are able to see how integrins express and disperse in the body, they can confirm their contribution to pathological processes. Such confirmation is essential in selecting the correct targets for therapy.

2. Drug Screening and Optimization

Imaging can be used to screen potential integrin-targeted compounds by measuring binding affinity, specificity and pharmacokinetics in vivo. With this non-invasive method, multiple candidate drugs can be evaluated quickly and optimisation is made easier. Also, imaging can tell us the biodistribution and off-target effect of drugs, which gives information about their safety profile.

3. Therapeutic Monitoring

Imaging integrin receptors in trials can track the response to integrin-targeted therapy. Imagery of v3 integrin expression in cancer patients who have received anti-angiogenic treatment, for instance, could identify early non-responders. This helps with individualised treatment adjustments and improves overall therapy.

4. Mechanistic Insights

Imaging integrin receptors yields mechanistic information about drug effect and disease. It's through the simulation of dynamic integrin expression and signalling that scientists can help to explain the molecular basis for therapeutic action and resistance. This information is invaluable when we're trying to fine-tune therapies and create combinations.

Our Services

Integrin Receptors Imaging Analysis

Case Studies and Clinical Applications

A couple of case studies and clinical use cases show how integrin receptor imaging has helped drug discovery.

1. Cancer Therapy

Imaging v3 integrin expression in oncology has been especially helpful. Clinical studies of [18F]Galacto-RGD PET imaging have shown its use in the identification of patients and treatment monitoring. The tumors of patients with increased v3 expression are better candidates for anti-angiogenic drugs like bevacizumab. Integrin scans can also reveal metastases displaying a high expression of v3, and guide surgery and radiotherapy.

2. Cardiovascular Disease

Even integrin imaging is improving cardiovascular studies. Imaging v3 integrin in atherosclerotic plaques gives us information about the stability and rupture of plaque, which is key to the prediction of adverse cardiovascular outcomes. It also helps to find personalised treatments to help balance delicate plaques and stop heart attacks or strokes.

3. Inflammatory Diseases

When imaging leukocyte integrins such as LFA-1 is used to see immune cell movement and infiltration of tissues in inflammatory conditions. It is an ability that is essential to assessing whether anti-inflammatory agents work and how they work. To demonstrate the effect of treatments on the migration of immune cells to painful joints, imaging LFA-1 expression in models of rheumatoid arthritis, for example.

Challenges and Future Directions

Integrin receptor imaging is a great idea, but it has its problems. To avoid off-target noise and improve signal-to-noise ratios, very specific and high-affinity imaging agents are needed. Additionally, imaging techniques must be tested and standardized before they can be brought from preclinical imaging to clinical practice.

The future of integrin receptor imaging involves multimodal imaging that combines the best of both worlds (PET/MRI or PET/CT, for example). These methods provide complete information about integrin biology by being functional and anatomical. More recently, molecular imaging probes such as activated probes that release a signal only after binding to integrins should enable greater imaging specificity and sensitivity.

AI/ML is a next big frontier for imaging analysis. These can be used to power image processing, quantification and interpretation to make integrin expression and drug response measurements more precise and effective.

Conclusion

Integrin receptor imaging is an important drug development technology, with significant advantages in target validation, drug screening, therapy monitoring and mechanistic analysis. Understanding how integrins behave in disease is much easier when they can be visualized in vivo, which enables the design of more specific, efficient treatments. With imaging technology maturing, and becoming integrated with other biomedical advances, there's still so much that can be done with integrin receptor imaging to transform drug discovery and patient care.

1. Bogdanović B, et al.; Integrin Targeting and Beyond: Enhancing Cancer Treatment with Dual-Targeting RGD (Arginine-Glycine-Aspartate) Strategies. Pharmaceuticals (Basel). 2024, 17(11):1556.

*If your organization requires the signing of a confidentiality agreement, please contact us by email.

Please note: Our services can only be used for research purposes. Do not use in diagnostic or therapeutic procedures!